Using psychosis biotypes and the Framingham model for parsing psychosis biology.
Schizophr Res
; 242: 132-134, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-35123865
ABSTRACT
The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) has invested in the collection and use of multiple biomarkers in individuals with psychosis. We expect psychosis biology and its distinctive types to be reflected in the biomarkers, as they are the 'behaviors' of the brain. Like infectious diseases, we expect the etiologies of these biomarker-driven entities to be multiple and complex. Biomarkers have not yet been annotated with disease characteristics and need to be. As a model, we seek to adopt aspects of the Framingham Heart Study (FHS) to guide and organize these observations.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psychotic Disorders
/
Schizophrenia
/
Bipolar Disorder
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Schizophr Res
Journal subject:
PSIQUIATRIA
Year:
2022
Document type:
Article